Categories: News

Safety Shot Appoints BONK Core Contributor Mitchell Rudy (Nom) to Board of Directors

Transition Marks Next Phase in Company’s Strategic Integration with the Digital Asset Ecosystem

SCOTTSDALE, AZ, Sept. 05, 2025 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT), a company evolving to bridge the gap between traditional public markets and the digital asset ecosystem, today announced the appointment of BONK core founder Mitchell Rudy (a.k.a. “Nom”) to its Board of Directors. Mr. Rudy’s appointment follows the resignation of Dave Long, who is stepping down from the board.

The appointment of Mr. Rudy, a key figure in the BONK ecosystem, aligns the Company’s governance directly with its new strategic focus on building a premier, publicly-traded vehicle for digital assets.

“We are thrilled to welcome Nom to our Board of Directors. His deep, native expertise in the Solana ecosystem and his focus on the institutional growth of BONK are invaluable as we execute on our new strategy,” said Jarrett Boon, CEO of Safety Shot. “I also want to extend our deepest gratitude to Dave Long for his dedicated service and significant contributions. His guidance has been instrumental in bringing Safety Shot to this exciting inflection point, and we wish him the very best in his future endeavors.”

Mr. Rudy has been an active developer and contributor in the Solana ecosystem since 2021. With a background as a traditional software developer focused on Natural Language Processing and Robot Process Automation, he became a core contributor to the BONK project in 2022. His current focus is on the evolving regulatory and institutional aspects of the BONK ecosystem.

“I am excited to join the Safety Shot board at this pivotal moment,” said Mr. Rudy. “We are building a first-of-its-kind bridge between the public markets and the vibrant BONK ecosystem, and I look forward to creating new revenue streams designed to support the Company’s balance sheet as it continues its growth in this new direction. I also want to thank Dave Long for his foundational work on the board; I am honored to help build upon the legacy he helped create.”

About Safety Shot, Inc. Safety Shot, Inc. (Nasdaq: SHOT), is a company evolving to bridge the gap between traditional public markets and the digital asset ecosystem. Following its strategic integration with letsBONK.fun, the Company is executing a new strategy focused on acquiring revenue-generating assets within the DeFi space to build a robust treasury of digital assets. The company’s beverage division holds the patented Safety Shot beverage, designed to rapidly reduce blood alcohol content as well as Yerbaé’s plant-based, energy beverage.

Investor Relations: Phone: 561-244-7100 Email: investors@drinksafetyshot.com

Forward-Looking Statements: This press release contains forward-looking statements. Such statements are subject to risks and uncertainties, many of which are outside of the Company’s control, and actual results could differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the performance of BONK tokens, the successful integration and operational success with letsBONK.fun, the ability to execute on the Company’s treasury strategy, and other risks detailed in Safety Shot’s filings with the Securities and Exchange Commission.

Staff

Recent Posts

Restart Life Sciences Announces Closing First Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

16 minutes ago

TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg

Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

17 minutes ago

Correction to MyndTec Inc. Press Release Issued December 3, 2025 Regarding Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 5, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), announced…

17 minutes ago

Atropos Health Expands Oncology Precision Medicine Capabilities with Publication of New AI Algorithms for Rare Disease and Integration of ASCO Guidelines

Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…

5 hours ago

USF and Old Dominion to Play in the 2025 StaffDNA Cure Bowl

PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…

5 hours ago

The Dot Corp Expands Services With New Promotional Products & Apparel Division

IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…

5 hours ago